HL Financial Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

HL Financial Services’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,670	Closed	-$969K	–	789
2018 Q3	$969K	Sell	7,670 -4,829	-39%	-$511K	0.02%	389
2018 Q2	$1.05M	Buy	12,499 +483	+4%	+$35.4K	0.02%	359
2018 Q1	$739K	Buy	12,016 +1,359	+13%	+$81.9K	0.01%	415
2017 Q4	$623K	Buy	+10,657	New	+$672K	0.01%	388

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HL Financial Services's ICPT Position: Q4 2018 in Review

HL Financial Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2018, closing a stake of 7,670 shares — an estimated $969K sold.

HL Financial Services first reported a position in ICPT in Q4 2017 and held it in 4 quarters. The position peaked at $1.05M in Q2 2018. 191 funds tracked by Wall St. Rank hold ICPT as of Q4 2018.

HL Financial Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
HL Financial Services sold 7,670 Intercept Pharmaceuticals, Inc. shares in Q4 2018, an estimated $969K.
HL Financial Services first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 4 quarters.
HL Financial Services's Intercept Pharmaceuticals, Inc. position peaked at $1.05M in Q2 2018.
191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2018.

Based on HL Financial Services's 13F filing for Q4 2018, filed 7 Feb 2019.